Transplantation of fresh amnion and preserved amnion for corneal alkali burn

Ke Hu,Min Zhao,Qi Zhang,Hong Li
DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.05.014
2008-01-01
Abstract:Aim: Recently, amnion transplantation has been one of effective methods for curing corneal alkali burn, but its biomechanism is unclear. This study was to discuss the efficiency of different kinds of amnion on rabbit corneal alkali burn and to find the bioactive functions of the amnion. Methods: The experiment was carried out in the Central Laboratory of Experimental Animals at Chongqing University of Medical Sciences between January and July in 2004. All the disposals were in accordance with the ethical standard of animals. 1 Placenta from healthy puerperants underwent uterine-incision delivery were offered by Department of Obstetrics in the First Affiliated Hospital of Chongqing University of Medical Sciences. A total of 45 New Zealand rabbits were used for corneal alkali burn models and divided into fresh amniotic membrane (FAM), glycerin preserved amniotic membrane (GPAM), vacuum xeransis amniotic membrane (VXAM), alcolhol preserved amniotic membrane (APAM) and control groups, every group had 9 rabbits. 2 The FAM was prepared within 24 hours, and the preserved amnion were transplanted after 1 month. 3 The corneal opacity and corneal neovascularization were observed everyday during days 2-21 after operation and once every three days after days 21; corneal fluorescein staining was conducted to observe the repair of corneal epithelium on days 14, 30, 60 after operation; 2 weeks, 1 month and 2 months after operation, we did histopathological examination and scanning electron microscope observation. Results: Forty-three rabbits were involved in the result analysis. 1 There were no significant differences in the corneal opacity and repair velocity of corneal epithelium among FAM, GPAM and VXAM, which were remarkably superior to APAM and controls. APAM group and control group had not distinct difference. 2 FAM had better effects on inhibiting corneal neovascularization than GPAM and VXAM. Conclusion: After transplantation, VXAM, GPAM and FAM can all accelerate corneal epithelial healing and lighten inflammation. FAM containing more bioactive materials, plays best.
What problem does this paper attempt to address?